slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
8,731-8,760 of 319,975
10
The slide uses a simple list-based framework to categorize 12 items into 3 groups of 4.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
13
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
14
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The diagram uses a flow-chart style to represent iterative loops and parallel processes within the pharmaceutical lifecycle.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
16
The slide uses a process flow diagram to map the medical device lifecycle, highlighting key milestones like NICE routing and local patient access.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
17
The slide uses a complex flow diagram to represent the regulatory and adoption pathway, mapping stages to time durations.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
18
The slide uses a two-part framework (A and B) to define the scope of the analysis.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
19
The slide uses a visual legend approach to map slide components to their descriptions.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
20
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
21
The slide uses a process-flow framework to categorize specific barriers alongside cross-cutting organizational challenges.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
22
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
23
The slide uses a complex flow diagram to differentiate development paths for three drug types.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
24
The slide uses a simple icon-based list structure to present qualitative findings from stakeholder interviews.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
25
The slide uses a hub-and-spoke diagram to connect stakeholder types to specific pain points.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
26
The slide uses a 2x2 grid layout to categorize stakeholder feedback.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
27
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
28
The slide uses a color-coded flow chart to distinguish between different product types (small molecules, biologics, vaccines) and their respective regulatory routes.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
29
The slide uses a process-like icon header to indicate the regulatory stage.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
30
The slide uses a hub-and-spoke diagram to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs) via color-coding.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
31
Uses a 2x2 grid layout to contrast different stakeholder viewpoints on regulatory processes.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
32
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
33
The slide uses a color-coded flow chart to distinguish between different drug types and their respective evaluation processes (NICE vs. Commissioning).Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
34
The slide uses a list-based structure to detail specific industry-public sector friction points.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
35
Uses a hub-and-spoke diagram to connect stakeholder quotes to a central figure representing the patient or the system.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
36
The slide uses a 2x2 matrix layout to contrast different stakeholder groups.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
37
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
38
The diagram uses a flow-chart style to map decision points (committees, stakeholder engagement, formulary listing) leading to patient access. It distinguishes between the 'iteration' phase across local health economies and the 'diffusion' phase.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
39
The slide uses a list-based structure to detail specific pain points identified through research.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit